Old Blood Pressure Drug Shows Promise Against Huntington’s Disease Chorea
A phase 2b European trial found that SOM3355, a repurposed beta-blocker with a novel triple mechanism, significantly reduced chorea in ...
A phase 2b European trial found that SOM3355, a repurposed beta-blocker with a novel triple mechanism, significantly reduced chorea in ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine